The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Pathophysiology of GvHD and Other HSCT-Related Major Complications
Open accessAbstract
For over 60 years, hematopoietic stem cell transplantation has been the major curative therapy for several hematological and genetic disorders, but its efficacy is limited by the secondary disease called graft versus host disease (GvHD). Huge advances have been made in successful transplantation in order to improve patient quality of life, and yet, complete success is hard to achieve. This review assimilates recent updates on pathophysiology of GvHD, prophylaxis and treatment of GvHD-related complications, and advances in the potential treatment of GvHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.004 · Cited by 3,556
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Ferrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
Self-citationLuznik, L., O'Donnell, P. V., Symons, H. J., Chen, A. R., Leffell, M. S., Zahurak, M., Gooley, T. A., Piantadosi, S., Kaup, M., Ambinder, R. F., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.005 · Cited by 1,938
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,493
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S., & Negrin, R. S. (2003) · Nature Medicine · doi:10.1038/nm915 · Cited by 1,288
Ferrara, J. L. M., & Deeg, H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241005 · Cited by 1,219
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J., & Emerson, S. G. (1999) · Science · doi:10.1126/science.285.5426.412 · Cited by 1,186
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R. I., Cecchini, D., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311894 · Cited by 1,064
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823
Mathewson, N. D., Jenq, R., Mathew, A. V., Koenigsknecht, M., Hanash, A., Toubai, T., Oravecz-Wilson, K., Wu, S.-R., Sun, Y., Rossi, C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3400 · Cited by 725
Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Löffler, J., Grigoleit, U., Moris, A., Rammensee, H.-G., Kanz, L., et al. (2002) · Blood · doi:10.1182/blood.v99.11.3916 · Cited by 699
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, F., Vossen, J., Gratwohl, A., Vogelsang, G. B., van Houwelingen, H. C., & van Rood, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340501 · Cited by 605
Nash, R. A., Antin, J. H., Karanes, C., Fay, J. W., Avalos, B. R., Yeager, A. M., Przepiorka, D., Davies, S. M., Petersen, F. B., Bartels, P., et al. (2000) · PubMed · Cited by 589
Hanash, A. M., Dudakov, J. A., Hua, G., O’Connor, M. H., Young, L. F., Singer, N. V., West, M. L., Jenq, R. R., Holland, A. M., Kappel, L. W., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.028 · Cited by 584
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
Martin, P., Schoch, G., Fisher, L., Byers, V, Appelbaum, F., McDonald, G., Storb, R., & Hansen, J. (1991) · Blood · doi:10.1182/blood.v77.8.1821.1821 · Cited by 566
Lee, S. J. (2002) · Blood · doi:10.1182/blood.v100.2.406 · Cited by 538
Bacigalupo, A., Lamparelli, T., Bruzzi, P., Guidi, S., Alessandrino, P. E., di Bartolomeo, P., Oneto, R., Bruno, B., Barbanti, M., Sacchi, N., et al. (2001) · Blood · doi:10.1182/blood.v98.10.2942 · Cited by 526
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C., Cooke, K. R., & Ferrara, J. L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-575 · Cited by 521
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
Martin, P., Schoch, G. H., Fisher, L. D., Byers, V. S., Anasetti, C., Appelbaum, F. R., Pg, B., Doney, K., McDonald, G., & Sanders, J. (1990) · Blood · doi:10.1182/blood.v76.8.1464.1464 · Cited by 454
Feuchtinger, T., Opherk, K., Bethge, W. A., Topp, M. S., Schuster, F. R., Weissinger, E. M., Mohty, M., Or, R., Maschan, M., Schumm, M., et al. (2010) · Blood · doi:10.1182/blood-2010-01-262089 · Cited by 435
Jodele, S., Davies, S. M., Lane, A., Khoury, J., Dandoy, C., Goebel, J., Myers, K., Grimley, M., Bleesing, J., El-Bietar, J., et al. (2014) · Blood · doi:10.1182/blood-2014-03-564997 · Cited by 419
The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism
den Haan, J. M. M., Meadows, L. M., Wang, W., Pool, J., Blokland, E., Bishop, T. L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt, D. F., et al. (1998) · Science · doi:10.1126/science.279.5353.1054 · Cited by 415
A biomarker panel for acute graft-versus-host disease
Paczesny, S., Krijanovski, O. I., Braun, T. M., Choi, S. W., Clouthier, S. G., Kuick, R., Misek, D. E., Cooke, K. R., Kitko, C. L., Weyand, A., et al. (2009) · Blood · doi:10.1182/blood-2008-07-167098 · Cited by 407
Miklos, D. B., Kim, H. T., Miller, K. H., Guo, L., Zorn, E., Lee, S. J., Hochberg, E. P., Wu, C. J., Alyea, E. P., Cutler, C., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3660 · Cited by 406
Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.52 · Cited by 387
Kernan, N., Collins, N., Juliano, L., Cartagena, T., Dupont, B., & O'Reilly, R. (1986) · Blood · doi:10.1182/blood.v68.3.770.770 · Cited by 365
Xun, C., Thompson, J., Jennings, C., Brown, S., & Widmer, M. (1994) · Blood · doi:10.1182/blood.v83.8.2360.2360 · Cited by 360
Jodele, S., Laskin, B. L., Dandoy, C. E., Myers, K. C., El-Bietar, J., Davies, S. M., Goebel, J., & Dixon, B. P. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.11.001 · Cited by 353
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
Ferrara, J. L. M., Harris, A. C., Greenson, J. K., Braun, T. M., Holler, E., Teshima, T., Levine, J. E., Choi, S. W. J., Huber, E., Landfried, K., et al. (2011) · Blood · doi:10.1182/blood-2011-08-375006 · Cited by 339
Self-citationY-antigen killing by T cells of women is restricted by HLA
Goulmy, E., Termijtelen, A., BRADLEY, B. A., & van Rood, J. J. (1977) · Nature · doi:10.1038/266544a0 · Cited by 328
Eriguchi, Y., Takashima, S., Oka, H., Shimoji, S., Nakamura, K., Uryu, H., Shimoda, S., Iwasaki, H., Shimono, N., Ayabe, T., et al. (2012) · Blood · doi:10.1182/blood-2011-12-401166 · Cited by 314
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
Levine, J. E., Braun, T. M., Harris, A. C., Holler, E., Taylor, A., Miller, H., Magenau, J., Weisdorf, D. J., Ho, V. T., Bolaños-Meade, J., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(14)00035-0 · Cited by 309
Self-citationBueger, M. M. D., Bakker, A., van Rood, J. J., van der Woude, F., & Goulmy, E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1788 · Cited by 298
The role of B cells in the pathogenesis of graft-versus-host disease
Shimabukuro-Vornhagen, A., Hallek, M. J., Storb, R. F., & von Bergwelt-Baildon, M. S. (2009) · Blood · doi:10.1182/blood-2008-10-161638 · Cited by 271
Treatment of Murine Leukaemia with X‐Rays and Homologous Bone Marrow: II
Barnes, D. W. H., & Loutit, J. F. (1957) · British Journal of Haematology · doi:10.1111/j.1365-2141.1957.tb05793.x · Cited by 271
Tumor necrosis factor-α blockade for the treatment of acute GVHD
Couriel, D., Saliba, R., Hicks, K., Ippoliti, C., de Lima, M., Hosing, C., Khouri, I., Andersson, B., Gajewski, J., Donato, M., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4241 · Cited by 261
Biedermann, B. C., Sahner, S., Gregor, M., Tsakiris, D. A., Jeanneret, C., Pober, J. S., & Gratwohl, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08907-9 · Cited by 253
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Paczesny, S., Braun, T. M., Levine, J. E., Hogan, J., Crawford, J., Coffing, B., Olsen, S., Choi, S. W., Wang, H., Faca, V., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000406 · Cited by 250
(2006) · Encyclopedic Reference of Immunotoxicology · doi:10.1007/3-540-27806-0_623 · Cited by 241
Ball, L. M., Bernardo, M. E., Roelofs, H., van Tol, M. J. D., Contoli, B., Zwaginga, J. J., Avanzini, M. A., Conforti, A., Bertaina, A., Giorgiani, G., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12545 · Cited by 240
Steroid-Refractory Acute GVHD: Predictors and Outcomes
Westin, J. R., Saliba, R. M., De Lima, M., Alousi, A., Hosing, C., Qazilbash, M. H., Khouri, I. F., Shpall, E. J., Anderlini, P., Rondon, G., et al. (2011) · Advances in Hematology · doi:10.1155/2011/601953 · Cited by 217
Gatza, E., Rogers, C. E., Clouthier, S. G., Lowler, K. P., Tawara, I., Liu, C., Reddy, P., & Ferrara, J. L. M. (2008) · Blood · doi:10.1182/blood-2007-11-125542 · Cited by 215
Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†
McDonald, G. B. (2010) · Hepatology · doi:10.1002/hep.23533 · Cited by 201
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system
Luft, T., Dietrich, S., Falk, C., Conzelmann, M., Hess, M., Benner, A., Neumann, F., Isermann, B., Hegenbart, U., Ho, A. D., et al. (2011) · Blood · doi:10.1182/blood-2011-02-334821 · Cited by 196
Weber, D., Oefner, P. J., Hiergeist, A., Koestler, J., Gessner, A., Weber, M., Hahn, J., Wolff, D., Stämmler, F., Spang, R., et al. (2015) · Blood · doi:10.1182/blood-2015-04-638858 · Cited by 195 · cited 1×
“In addition, as stated earlier, it was proposed that regenerating islet-derived 3-a (reg3a), released from Paneth cells, was a potential plasma biomarker for lower GI GvHD (63), Paneth cell damage contributes to loss of antimicrobial peptides and accelerates the loss of microbial diversity in GvHD, a major risk factor…”
BackgroundTheil, A., Tuve, S., Oelschlägel, U., Maiwald, A., Döhler, D., Oßmann, D., Zenkel, A., Wilhelm, C., Middeke, J. M., Shayegi, N., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.11.005 · Cited by 180
Hildebrandt, G. C., Fazekas, T., Lawitschka, A., Bertz, H., Greinix, H., Halter, J., Pavletic, S. Z., Holler, E., & Wolff, D. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.35 · Cited by 178
Self-citationGraft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors
Penack, O., Holler, E., & van den Brink, M. R. M. (2009) · Blood · doi:10.1182/blood-2009-09-242784 · Cited by 174
Self-citationRegulatory T cells in stem cell transplantation: strategies and first clinical experiences
Edinger, M., & Hoffmann, P. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.06.006 · Cited by 167
Levine, J. E., Huber, E., Hammer, S. T. G., Harris, A. C., Greenson, J. K., Braun, T., Ferrara, J. L. M., & Holler, E. (2013) · Blood · doi:10.1182/blood-2013-02-485813 · Cited by 159
Self-citationAntin, J. H., Kim, H. T., Cutler, C. S., Ho, V. T., Lee, S. J., Miklos, D. B., Hochberg, E. P., Wu, C. J., Alyea, E. P., & Soiffer, R. J. (2003) · Blood · doi:10.1182/blood-2003-02-0489 · Cited by 153
Plasma biomarkers of lower gastrointestinal and liver acute GVHD
Harris, A. C., Ferrara, J. L. M., Braun, T., Holler, E., Teshima, T., Levine, J. E., Choi, S. W., Landfried, K., Akashi, K., Lugt, M. T. V., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387357 · Cited by 144
Self-citationGraft-versus-host reactions in dermatology
Johnson, M. L., & Farmer, E. R. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70495-5 · Cited by 135
Koehn, B. H., Apostolova, P., Haverkamp, J. M., Miller, J. S., McCullar, V., Tolar, J., Munn, D. H., Murphy, W. J., Brickey, W. J., Serody, J. S., et al. (2015) · Blood · doi:10.1182/blood-2015-03-634691 · Cited by 128
Aberrant B-cell homeostasis in chronic GVHD
Sarantopoulos, S., & Ritz, J. (2015) · Blood · doi:10.1182/blood-2014-12-567834 · Cited by 126
Acute Graft-versus-Host Disease: Novel Biological Insights
Teshima, T., Reddy, P., & Zeiser, R. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.10.001 · Cited by 125
Geissler, E. K. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-11 · Cited by 115
Advances in predicting acute GVHD
Harris, A. C., Ferrara, J. L. M., & Levine, J. E. (2012) · British Journal of Haematology · doi:10.1111/bjh.12142 · Cited by 109
NOD2 regulates hematopoietic cell function during graft-versus-host disease
Penack, O., Smith, O. M., Cunningham‐Bussel, A., Liu, X., Rao, U. K., Yim, N. L., Na, I., Holland, A. M., Ghosh, A., Lu, S. X., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090623 · Cited by 109
Minor histocompatibility antigens: past, present, and future
Spierings, E. (2014) · Tissue Antigens · doi:10.1111/tan.12445 · Cited by 101
Vascular endothelium and graft-versus-host disease
Biedermann, B. C. (2008) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.02.003 · Cited by 95
Controlling the frontier: Regulatory T-cells and intestinal homeostasis
Bollrath, J., & Powrie, F. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.002 · Cited by 93
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality
Schneidawind, D., Baker, J. B., Pierini, A., Buechele, C., Luong, R. H., Meyer, E. H., & Negrin, R. S. (2015) · Blood · doi:10.1182/blood-2014-11-612762 · Cited by 91
Markey, K. A., Banovic, T., Kuns, R. D., Olver, S. D., Don, A. L. J., Raffelt, N. C., Wilson, Y. A., Raggatt, L. J., Pettit, A. R., Bromberg, J. S., et al. (2009) · Blood · doi:10.1182/blood-2008-12-191833 · Cited by 89
Varelias, A., Gartlan, K. H., Kreijveld, E., Olver, S. D., Lor, M., Kuns, R. D., Lineburg, K. E., Teal, B. E., Raffelt, N. C., Cheong, M., et al. (2015) · Blood · doi:10.1182/blood-2014-07-590232 · Cited by 87
Role of intestinal microbiota in transplantation outcomes
Taur, Y., Jenq, R. R., Úbeda, C., van den Brink, M. R. M., & Pamer, E. G. (2015) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2015.10.013 · Cited by 84
Penack, O., Socié, G., & van den Brink, M. R. M. (2011) · Blood · doi:10.1182/blood-2010-10-312934 · Cited by 80
Clinical impact of H-Y alloimmunity
Popli, R., Sahaf, B., Nakasone, H., Lee, J. Y. Y., & Miklos, D. B. (2014) · Immunologic Research · doi:10.1007/s12026-014-8514-3 · Cited by 80
Leonhardt, F., Grundmann, S., Béhé, M. P., Bluhm, F., Dumont, R. A., Braun, F., Fani, M., Riesner, K., Prinz, G., Hechinger, A.-K., et al. (2013) · Blood · doi:10.1182/blood-2012-07-442665 · Cited by 75
Finke, J., Schmoor, C., Lang, H., Potthoff, K., & Bertz, H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.129 · Cited by 73
Ahmed, S. S., Wang, X. N., Norden, J., Pearce, K. F., Elgezawy, E., Atarod, S., Hromadníková, I., Collin, M. P., Holler, E., & Dickinson, A. M. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.191 · Cited by 72
Self-citationMori, T., Nishimura, T., Ikeda, Y., Hotta, T., Yagita∥, H., & Ando, K. (1998) · Blood · doi:10.1182/blood.v92.1.101.413k14_101_107 · Cited by 66
Holtan, S. G., Verneris, M. R., Schultz, K. R., Newell, L. F., Meyers, G., He, F. C., DeFor, T. E., Vercellotti, G. M., Slungaard, A., MacMillan, M. L., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.02.018 · Cited by 63
Penack, O., Henke, E., Suh, D. Y., King, C. G., Smith, O. M., Na, I., Holland, A. M., Ghosh, A., Lu, S. X., Jenq, R. R., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq172 · Cited by 60
Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation
Cheng, G., Edelman, J. D., Madtes, D. K., Martin, P. J., & Flowers, M. E. D. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.04.008 · Cited by 57
The Treatment of Chronic Graft-Versus-Host Disease
Wolff, D., Bertz, H., Greinix, H. T., Lawitschka, Á., Halter, J. P., & Holler, E. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0732 · Cited by 55
Self-citationRole of gut flora after bone marrow transplantation
Peled, J. U., Jenq, R. R., Holler, E., & van den Brink, M. R. M. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.36 · Cited by 54
Self-citationMany faces of graft‐versus‐host disease
Fernández‐Peñas, P., & Zaman, S. J. (2009) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2009.00577.x · Cited by 46
Andrulis, M., Dietrich, S., Longerich, T., Koschny, R., Burian, M., Schmitt-Graf, A., Schirmacher, P., Ho, A. D., Dreger, P., & Luft, T. (2012) · Haematologica · doi:10.3324/haematol.2011.061051 · Cited by 42
THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
Stavrou, E. X., & Lazarus, H. M. (2010) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2010.033 · Cited by 37
Human Regulatory T Cells Mediate Transcriptional Modulation of Dendritic Cell Function
Mavin, E., Nicholson, L. K., Ahmed, S. R., Gao, F., Dickinson, A. M., & Wang, X. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502487 · Cited by 36
Self-citationMoll, G., & Blanc, K. L. (2015) · ISBT Science Series · doi:10.1111/voxs.12133 · Cited by 33
Maschmeyer, G., & Donnelly, J. P. (2016) · British Journal of Haematology · doi:10.1111/bjh.13934 · Cited by 28
Caring for the long-term survivor after allogeneic stem cell transplantation
Bhatia, R. (2014) · Hematology · doi:10.1182/asheducation-2014.1.495 · Cited by 26
Schmid, P. M., Bouazzaoui, A., Doser, K., Schmid, K., Hoffmann, P., Schroeder, J. A., Riegger, G. A. J., Holler, E., & Endemann, D. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.05.002 · Cited by 24
Self-citationNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment
Pierini, A., Álvarez, M., & Negrin, R. S. (2016) · Stem Cells International · doi:10.1155/2016/9025835 · Cited by 20
The role of danger signals and ectonucleotidases in acute graft-versus-host disease
Apostolova, P., & Zeiser, R. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.02.005 · Cited by 19
Novota, P., Zinöcker, S., Norden, J., Wang, X. N., Sviland, L., Opitz, L., Salinas, G., Rolstad, B., Dickinson, A. M., Walter, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016582 · Cited by 18
Self-citationThe molecular basis of allorecognition assessment of the involvement of peptide
Newton‐Nash, D. K. (1994) · Human Immunology · doi:10.1016/0198-8859(94)90002-7 · Cited by 18
Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
Villa, N., & McFadden, G. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0186-6 · Cited by 9
Zinöcker, S., Dressel, R., Wang, X., Dickinson, A. M., & Rolstad, B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00355 · Cited by 8
Self-citation
Metadata
- Authors
- Ghimire, S., Weber, D., Mavin, E., Wang, X. N., Dickinson, A. M., & Holler, E.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-20
- Volume
- 8
- Pages
- 79-79
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2597974085
- Cited by
- 256
- References
- 103
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.